Whole-body high-field MRI shows no skeletal muscle degeneration in young patients with recessive myotonia congenita
December 30th, 2009 Posted by: admin
Kornblum C, Lutterbey GG, Czermin B, Reimann J, von Kleist-Retzow J-C, Jurkat-Rott K, Wattjes MP. Whole-body high-field MRI shows no skeletal muscle degeneration in young patients with recessive myotonia congenita.Acta Neurol Scand: 2010: 121: 131[ndash]135.© 2009 The Authors Journal compilation © 2009 Blackwell Munksgaard.Background [ndash] Muscle magnetic resonance imaging (MRI) is the most sensitive method in the detection of dystrophic and non-dystrophic abnormalities within striated muscles. We hypothesized that in severe myotonia congenita type Becker muscle stiffness, prolonged transient weakness and muscle hypertrophy might finally result in morphologic skeletal muscle alterations reflected by MRI signal changes.Aim of the study [ndash] To assess dystrophic and/or non-dystrophic alterations such as fatty or connective tissue replacement and muscle edema in patients with severe recessive myotonia congenita.Methods [ndash] We studied three seriously affected patients with myotonia congenita type Becker using multisequence whole-body high-field MRI. All patients had molecular genetic testing of the muscle chloride channel gene (CLCN1).Results [ndash] Molecular genetic analyses demonstrated recessive CLCN1 mutations in all patients. Two related patients were compound heterozygous for two novel CLCN1 mutations, Q160H and L657P. None of the patients showed skeletal muscle signal changes indicative of fatty muscle degeneration or edema. Two patients showed muscle bulk hypertrophy of thighs and calves in line with the clinical appearance.Conclusions [ndash] We conclude that (i) chloride channel dysfunction alone does not result in skeletal muscle morphologic changes even in advanced stages of myotonia congenita, and (ii) MRI skeletal muscle alterations in myotonic dystrophy must be clear consequences of the dystrophic disease process.
Similar Posts:
- Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
- Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
- Comparison of Olmesartan Medoxomil Versus Amlodipine Besylate on Regression of Ventricular and Vascular Hypertrophy
- Re-evaluation of the dysequilibrium syndrome
- Mutation-Specific Risk in Two Genetic Forms of Type 3 Long QT Syndrome
- Ischiofemoral Impingement Syndrome: An Entity With Hip Pain and Abnormalities of the Quadratus Femoris Muscle
- Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis.
- Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis.
- Parkinson-related genetics in patients treated with deep brain stimulation
- Review of muscle wasting associated with chronic kidney disease.